CN Stock MarketDetailed Quotes

000597 Northeast Pharmaceutical Group

Watchlist
  • 5.36
  • -0.10-1.83%
Market Closed Dec 30 15:00 CST
7.66BMarket Cap22.06P/E (TTM)

Northeast Pharmaceutical Group Key Stats

All
YOY yoy
Hide blank lines yoy
(Q9)Sep 30, 2024
(Q6)Jun 30, 2024
(Q3)Mar 31, 2024
(FY)Dec 31, 2023
(Q9)Sep 30, 2023
(Q6)Jun 30, 2023
(Q3)Mar 31, 2023
(FY)Dec 31, 2022
(Q9)Sep 30, 2022
(Q6)Jun 30, 2022
Total operating revenue
-4.22%6.13B
-7.50%4.17B
-17.58%1.94B
-6.42%8.24B
-2.52%6.4B
1.95%4.51B
0.02%2.35B
8.15%8.81B
7.60%6.57B
10.23%4.42B
Operating revenue
-4.22%6.13B
-7.50%4.17B
-17.58%1.94B
-6.42%8.24B
-2.52%6.4B
1.95%4.51B
0.02%2.35B
8.15%8.81B
7.60%6.57B
10.23%4.42B
Other operating revenue
----
-43.47%16.59M
----
-34.58%58.56M
----
7.31%29.36M
----
-9.32%89.5M
----
-33.83%27.36M
Total operating cost
-4.02%5.78B
-8.67%3.88B
-18.64%1.82B
-9.14%7.66B
-3.92%6.03B
0.95%4.25B
-0.78%2.24B
5.83%8.44B
4.09%6.27B
7.69%4.21B
Operating cost
6.16%4.02B
4.69%2.69B
-9.10%1.2B
-9.06%4.89B
-6.16%3.78B
-5.23%2.57B
-8.33%1.32B
9.10%5.38B
8.49%4.03B
12.68%2.71B
Operating tax surcharges
-13.62%53.45M
-17.44%35.59M
-19.35%17.67M
-1.66%81.75M
0.64%61.88M
4.34%43.1M
6.72%21.91M
-0.88%83.13M
-5.84%61.49M
-1.86%41.31M
Operating expense
-29.25%1.05B
-34.77%723.18M
-33.89%386.75M
-11.76%1.81B
-0.72%1.48B
12.38%1.11B
9.82%585.04M
1.72%2.05B
-0.10%1.49B
-0.42%986.54M
Administration expense
-12.54%619.71M
-24.86%422.33M
-33.67%204.15M
7.92%815.55M
11.19%708.52M
28.90%562.04M
32.06%307.76M
1.75%755.71M
1.13%637.2M
11.22%436.03M
Financial expense
87.54%-6.24M
55.98%-25.48M
46.68%-5.84M
-478.84%-29.97M
-774.81%-50.08M
-1,152.19%-57.9M
-263.89%-10.95M
-93.13%7.91M
-106.54%-5.72M
-108.03%-4.62M
-Interest expense (Financial expense)
-6.47%53.03M
-10.79%35.97M
-8.57%17.9M
-15.98%77.39M
-16.81%56.7M
-8.77%40.32M
-12.66%19.57M
-23.34%92.11M
-23.75%68.15M
-27.59%44.2M
-Interest Income (Financial expense)
18.04%-101.23M
23.53%-77.18M
32.17%-25.69M
-65.18%-155.08M
-82.97%-123.52M
-130.11%-100.93M
-91.35%-37.87M
-67.88%-93.88M
-142.07%-67.51M
-125.08%-43.86M
Research and development
26.41%53.42M
44.02%35.98M
34.34%17.04M
-39.50%97.04M
-25.31%42.26M
-36.95%24.98M
-40.05%12.68M
92.18%160.39M
66.37%56.58M
87.90%39.63M
Credit Impairment Loss
-156.48%-1.67M
-413.52%-2.98M
138.62%257.5K
132.47%6.79M
137.78%2.96M
109.95%952.08K
83.26%-666.68K
-31.24%-20.9M
-453.54%-7.84M
-440.53%-9.57M
Asset Impairment Loss
41.13%-81.63M
47.46%-66.27M
-11.76%-37.67M
-30.54%-193.49M
-27.15%-138.66M
-57.42%-126.12M
-22.91%-33.7M
-55.39%-148.23M
-142.15%-109.06M
-108.92%-80.11M
Other net revenue
78.38%-13.99M
88.28%-7.56M
68.83%-3.51M
-124.99%-80.67M
8.14%-64.72M
-0.41%-64.47M
26.56%-11.26M
2,437.36%322.84M
-4,935.75%-70.46M
-500.50%-64.21M
Invest income
-58.48%3.44M
-61.52%2.93M
--2.27M
--8.61M
--8.29M
--7.62M
----
----
--0
----
Asset deal income
-96.15%6.65K
-96.17%6.65K
-90.86%6.65K
-99.96%172.21K
500.58%172.91K
328.89%173.92K
79.48%72.78K
12,641.67%419.3M
-101.96%-43.16K
1,263.60%40.55K
Other revenue
5.35%65.86M
11.08%58.75M
37.26%31.62M
33.84%97.26M
34.49%62.51M
107.98%52.9M
43.71%23.04M
9.40%72.67M
18.51%46.48M
2.38%25.43M
Operating profit
7.21%336.36M
46.05%278.3M
10.06%117.67M
-28.45%498.23M
37.80%313.74M
31.77%190.56M
26.22%106.92M
271.69%696.36M
188.73%227.67M
63.51%144.61M
Add:Non operating Income
5.72%15.95M
-52.26%3.83M
-68.65%2.36M
-4.71%28.99M
-25.24%15.09M
-50.02%8.02M
260.63%7.54M
344.36%30.43M
436.46%20.18M
551.38%16.04M
Less:Non operating expense
-87.00%3.27M
-25.54%3.37M
6,746.51%3.6M
-80.61%39.05M
-35.90%25.18M
376.06%4.53M
-93.75%52.53K
171.96%201.34M
44.57%39.28M
-90.81%950.9K
Total profit
14.95%349.04M
43.66%278.76M
1.78%116.43M
-7.09%488.17M
45.59%303.64M
21.51%194.05M
33.09%114.4M
337.27%525.44M
276.18%208.57M
98.24%159.7M
Less:Income tax cost
86.47%128.98M
127.28%111.86M
37.75%56.65M
-33.33%112.19M
-3.85%69.17M
20.38%49.22M
207.79%41.13M
580.72%168.28M
170.76%71.94M
131.72%40.88M
Net profit
-6.15%220.05M
15.24%166.89M
-18.41%59.78M
5.27%375.98M
71.62%234.47M
21.90%144.83M
0.94%73.27M
274.22%357.16M
373.20%136.63M
88.85%118.81M
Net profit from continuing operation
-6.15%220.05M
15.24%166.89M
-18.41%59.78M
5.27%375.98M
71.62%234.47M
21.90%144.83M
0.94%73.27M
274.22%357.16M
373.20%136.63M
88.85%118.81M
Less:Minority Profit
-17.74%12.09M
1.43%10.09M
-33.40%2.15M
153.76%17.52M
73.10%14.69M
59.80%9.94M
-24.36%3.22M
292.55%6.9M
151.46%8.49M
146.05%6.22M
Net profit of parent company owners
-5.37%207.97M
16.25%156.81M
-17.72%57.63M
2.34%358.46M
71.52%219.78M
19.80%134.89M
2.51%70.05M
253.69%350.25M
402.55%128.14M
86.46%112.59M
Earning per share
Basic earning per share
-5.03%0.1455
17.02%0.11
-18.37%0.04
0.00%0.25
63.15%0.1532
12.57%0.094
-3.92%0.049
257.14%0.25
396.83%0.0939
85.56%0.0835
Diluted earning per share
-5.03%0.1455
17.02%0.11
-18.37%0.04
0.00%0.25
63.15%0.1532
12.57%0.094
-3.92%0.049
257.14%0.25
396.83%0.0939
85.56%0.0835
Other composite income
-131.84%-451.41K
-85.24%238.72K
135.84%66.13K
-69.04%921.94K
-63.85%1.42M
-11.33%1.62M
-42.26%-184.5K
619.62%2.98M
3,657.81%3.92M
971.61%1.82M
Other composite income of parent company owners
-131.98%-453.41K
-85.18%239.91K
134.51%66.47K
-69.13%919.41K
-63.98%1.42M
-11.62%1.62M
-46.92%-192.64K
619.62%2.98M
3,636.47%3.94M
968.07%1.83M
Other composite income of minority owners
2,675.74%1.99K
8.59%-1.19K
-104.23%-344.1
--2.53K
99.44%-77.36
82.84%-1.3K
470.47%8.14K
----
-1,403.55%-13.73K
-539.81%-7.6K
Total composite income
-6.90%219.6M
14.13%167.13M
-18.12%59.85M
4.66%376.9M
67.83%235.89M
21.39%146.45M
0.86%73.09M
279.62%360.13M
388.65%140.55M
92.39%120.64M
Total composite income of parent company owners
-6.19%207.52M
15.05%157.05M
-17.40%57.7M
1.74%359.38M
67.48%221.2M
19.30%136.5M
2.43%69.86M
258.78%353.23M
420.26%132.07M
90.16%114.42M
Total composite income of minority owners
-17.72%12.09M
1.43%10.08M
-33.58%2.15M
153.80%17.52M
73.38%14.69M
59.97%9.94M
-24.19%3.23M
292.55%6.9M
150.98%8.47M
145.59%6.21M
Currency Unit
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
Accounting Standards
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
Audit Opinions
--
--
--
Unqualified opinion
--
--
--
Unqualified opinion
--
--
Auditor
--
--
--
Grant Thornton Certified Public Accountants (Special General Partnership)
--
--
--
Grant Thornton Certified Public Accountants (Special General Partnership)
--
--
(Q9)Sep 30, 2024(Q6)Jun 30, 2024(Q3)Mar 31, 2024(FY)Dec 31, 2023(Q9)Sep 30, 2023(Q6)Jun 30, 2023(Q3)Mar 31, 2023(FY)Dec 31, 2022(Q9)Sep 30, 2022(Q6)Jun 30, 2022
Total operating revenue -4.22%6.13B-7.50%4.17B-17.58%1.94B-6.42%8.24B-2.52%6.4B1.95%4.51B0.02%2.35B8.15%8.81B7.60%6.57B10.23%4.42B
Operating revenue -4.22%6.13B-7.50%4.17B-17.58%1.94B-6.42%8.24B-2.52%6.4B1.95%4.51B0.02%2.35B8.15%8.81B7.60%6.57B10.23%4.42B
Other operating revenue -----43.47%16.59M-----34.58%58.56M----7.31%29.36M-----9.32%89.5M-----33.83%27.36M
Total operating cost -4.02%5.78B-8.67%3.88B-18.64%1.82B-9.14%7.66B-3.92%6.03B0.95%4.25B-0.78%2.24B5.83%8.44B4.09%6.27B7.69%4.21B
Operating cost 6.16%4.02B4.69%2.69B-9.10%1.2B-9.06%4.89B-6.16%3.78B-5.23%2.57B-8.33%1.32B9.10%5.38B8.49%4.03B12.68%2.71B
Operating tax surcharges -13.62%53.45M-17.44%35.59M-19.35%17.67M-1.66%81.75M0.64%61.88M4.34%43.1M6.72%21.91M-0.88%83.13M-5.84%61.49M-1.86%41.31M
Operating expense -29.25%1.05B-34.77%723.18M-33.89%386.75M-11.76%1.81B-0.72%1.48B12.38%1.11B9.82%585.04M1.72%2.05B-0.10%1.49B-0.42%986.54M
Administration expense -12.54%619.71M-24.86%422.33M-33.67%204.15M7.92%815.55M11.19%708.52M28.90%562.04M32.06%307.76M1.75%755.71M1.13%637.2M11.22%436.03M
Financial expense 87.54%-6.24M55.98%-25.48M46.68%-5.84M-478.84%-29.97M-774.81%-50.08M-1,152.19%-57.9M-263.89%-10.95M-93.13%7.91M-106.54%-5.72M-108.03%-4.62M
-Interest expense (Financial expense) -6.47%53.03M-10.79%35.97M-8.57%17.9M-15.98%77.39M-16.81%56.7M-8.77%40.32M-12.66%19.57M-23.34%92.11M-23.75%68.15M-27.59%44.2M
-Interest Income (Financial expense) 18.04%-101.23M23.53%-77.18M32.17%-25.69M-65.18%-155.08M-82.97%-123.52M-130.11%-100.93M-91.35%-37.87M-67.88%-93.88M-142.07%-67.51M-125.08%-43.86M
Research and development 26.41%53.42M44.02%35.98M34.34%17.04M-39.50%97.04M-25.31%42.26M-36.95%24.98M-40.05%12.68M92.18%160.39M66.37%56.58M87.90%39.63M
Credit Impairment Loss -156.48%-1.67M-413.52%-2.98M138.62%257.5K132.47%6.79M137.78%2.96M109.95%952.08K83.26%-666.68K-31.24%-20.9M-453.54%-7.84M-440.53%-9.57M
Asset Impairment Loss 41.13%-81.63M47.46%-66.27M-11.76%-37.67M-30.54%-193.49M-27.15%-138.66M-57.42%-126.12M-22.91%-33.7M-55.39%-148.23M-142.15%-109.06M-108.92%-80.11M
Other net revenue 78.38%-13.99M88.28%-7.56M68.83%-3.51M-124.99%-80.67M8.14%-64.72M-0.41%-64.47M26.56%-11.26M2,437.36%322.84M-4,935.75%-70.46M-500.50%-64.21M
Invest income -58.48%3.44M-61.52%2.93M--2.27M--8.61M--8.29M--7.62M----------0----
Asset deal income -96.15%6.65K-96.17%6.65K-90.86%6.65K-99.96%172.21K500.58%172.91K328.89%173.92K79.48%72.78K12,641.67%419.3M-101.96%-43.16K1,263.60%40.55K
Other revenue 5.35%65.86M11.08%58.75M37.26%31.62M33.84%97.26M34.49%62.51M107.98%52.9M43.71%23.04M9.40%72.67M18.51%46.48M2.38%25.43M
Operating profit 7.21%336.36M46.05%278.3M10.06%117.67M-28.45%498.23M37.80%313.74M31.77%190.56M26.22%106.92M271.69%696.36M188.73%227.67M63.51%144.61M
Add:Non operating Income 5.72%15.95M-52.26%3.83M-68.65%2.36M-4.71%28.99M-25.24%15.09M-50.02%8.02M260.63%7.54M344.36%30.43M436.46%20.18M551.38%16.04M
Less:Non operating expense -87.00%3.27M-25.54%3.37M6,746.51%3.6M-80.61%39.05M-35.90%25.18M376.06%4.53M-93.75%52.53K171.96%201.34M44.57%39.28M-90.81%950.9K
Total profit 14.95%349.04M43.66%278.76M1.78%116.43M-7.09%488.17M45.59%303.64M21.51%194.05M33.09%114.4M337.27%525.44M276.18%208.57M98.24%159.7M
Less:Income tax cost 86.47%128.98M127.28%111.86M37.75%56.65M-33.33%112.19M-3.85%69.17M20.38%49.22M207.79%41.13M580.72%168.28M170.76%71.94M131.72%40.88M
Net profit -6.15%220.05M15.24%166.89M-18.41%59.78M5.27%375.98M71.62%234.47M21.90%144.83M0.94%73.27M274.22%357.16M373.20%136.63M88.85%118.81M
Net profit from continuing operation -6.15%220.05M15.24%166.89M-18.41%59.78M5.27%375.98M71.62%234.47M21.90%144.83M0.94%73.27M274.22%357.16M373.20%136.63M88.85%118.81M
Less:Minority Profit -17.74%12.09M1.43%10.09M-33.40%2.15M153.76%17.52M73.10%14.69M59.80%9.94M-24.36%3.22M292.55%6.9M151.46%8.49M146.05%6.22M
Net profit of parent company owners -5.37%207.97M16.25%156.81M-17.72%57.63M2.34%358.46M71.52%219.78M19.80%134.89M2.51%70.05M253.69%350.25M402.55%128.14M86.46%112.59M
Earning per share
Basic earning per share -5.03%0.145517.02%0.11-18.37%0.040.00%0.2563.15%0.153212.57%0.094-3.92%0.049257.14%0.25396.83%0.093985.56%0.0835
Diluted earning per share -5.03%0.145517.02%0.11-18.37%0.040.00%0.2563.15%0.153212.57%0.094-3.92%0.049257.14%0.25396.83%0.093985.56%0.0835
Other composite income -131.84%-451.41K-85.24%238.72K135.84%66.13K-69.04%921.94K-63.85%1.42M-11.33%1.62M-42.26%-184.5K619.62%2.98M3,657.81%3.92M971.61%1.82M
Other composite income of parent company owners -131.98%-453.41K-85.18%239.91K134.51%66.47K-69.13%919.41K-63.98%1.42M-11.62%1.62M-46.92%-192.64K619.62%2.98M3,636.47%3.94M968.07%1.83M
Other composite income of minority owners 2,675.74%1.99K8.59%-1.19K-104.23%-344.1--2.53K99.44%-77.3682.84%-1.3K470.47%8.14K-----1,403.55%-13.73K-539.81%-7.6K
Total composite income -6.90%219.6M14.13%167.13M-18.12%59.85M4.66%376.9M67.83%235.89M21.39%146.45M0.86%73.09M279.62%360.13M388.65%140.55M92.39%120.64M
Total composite income of parent company owners -6.19%207.52M15.05%157.05M-17.40%57.7M1.74%359.38M67.48%221.2M19.30%136.5M2.43%69.86M258.78%353.23M420.26%132.07M90.16%114.42M
Total composite income of minority owners -17.72%12.09M1.43%10.08M-33.58%2.15M153.80%17.52M73.38%14.69M59.97%9.94M-24.19%3.23M292.55%6.9M150.98%8.47M145.59%6.21M
Currency Unit CNYCNYCNYCNYCNYCNYCNYCNYCNYCNY
Accounting Standards CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)
Audit Opinions ------Unqualified opinion------Unqualified opinion----
Auditor ------Grant Thornton Certified Public Accountants (Special General Partnership)------Grant Thornton Certified Public Accountants (Special General Partnership)----

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.